Rafferty Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-88,541
Closed -$8.79M 924
2019
Q3
$8.79M Buy
88,541
+10,594
+14% +$1.01M 0.14% 78
2019
Q2
$7.21M Sell
77,947
-29,366
-27% -$2.79M 0.13% 101
2019
Q1
$10.1M Buy
107,313
+81,607
+317% +$7.14M 0.16% 67
2018
Q4
$1.65M Sell
25,706
-5,955
-19% -$440K 0.04% 256
2018
Q3
$2.83M Sell
31,661
-488
-2% -$43.1K 0.04% 204
2018
Q2
$2.55M Buy
32,149
+12,513
+64% +$1.04M 0.04% 229
2018
Q1
$1.75M Buy
19,636
+6,054
+45% +$581K 0.03% 318
2017
Q4
$1.42M Buy
13,582
+2,574
+23% +$290K 0.02% 368
2017
Q3
$1.6M Sell
11,008
-7,652
-41% -$1.04M 0.04% 278
2017
Q2
$2.42M Buy
18,660
+9,518
+104% +$1.17M 0.07% 185
2017
Q1
$1.14M Buy
9,142
+508
+6% +$60.8K 0.03% 322
2016
Q4
$999K Buy
8,634
+1,870
+28% +$208K 0.05% 198
2016
Q3
$707K Buy
6,764
+811
+14% +$87.8K 0.03% 275
2016
Q2
$587K Sell
5,953
-1,933
-25% -$200K 0.04% 334
2016
Q1
$789K Buy
7,886
+113
+1% +$11.6K 0.04% 303
2015
Q4
$938K Buy
7,773
+560
+8% +$64.8K 0.11% 211
2015
Q3
$780K Sell
7,213
-1,620
-18% -$201K 0.06% 288
2015
Q2
$1.02M Buy
8,833
+1,038
+13% +$119K 0.07% 219
2015
Q1
$899K Buy
7,795
+2,733
+54% +$327K 0.07% 246
2014
Q4
$566K Buy
5,062
+498
+11% +$52.5K 0.13% 171
2014
Q3
$433K Buy
4,564
+1,831
+67% +$165K 0.05% 179
2014
Q2
$235K Sell
2,733
-2,615
-49% -$199K 0.05% 288
2014
Q1
$373K Buy
5,348
+1,386
+35% +$110K 0.08% 128
2013
Q4
$335K Buy
+3,962
New +$314K 0.08% 153

Other funds holding CELG

Rafferty Asset Management's CELG Position: Q4 2019 in Review

Rafferty Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 88,541 shares — an estimated $8.79M sold.

Rafferty Asset Management first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $10.1M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Rafferty Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 88,541 Celgene Corp shares in Q4 2019, an estimated $8.79M.
  • Rafferty Asset Management first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
  • Rafferty Asset Management's Celgene Corp position peaked at $10.1M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Rafferty Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.